Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach

Anne Lynn S. Chang(Stanford University), Joyce Teng(Stanford University)

American Journal of Dermatopathology

April 22, 2024

10.1097/dad.0000000000002718

Cited by 2

Related Papers

Text2Shape: Generating Shapes from Natural Language by Learning Joint Embeddings

|Lecture notes in computer science|2019|165

LBA47 Primary analysis of phase II results for cemiplimab in patients (pts) with locally advanced basal cell carcinoma (laBCC) who progress on or are intolerant to hedgehog inhibitors (HHIs)

|Annals of Oncology|2020|14